The Q1 2026 filing presents a classic high-growth, high-risk profile. Rigetti is successfully moving its technology out of the lab and into the market, as evidenced by the surge in hardware revenue and the strategic alignment with Quanta. The shift toward international commercial demand and the deployment of the 108-qubit system are positive indicators of product-market fit. However, the gap between the company's current revenue and its operational spend remains vast, leaving the stock highly sensitive to any delays in its technology roadmap.
Ultimately, the investment case hinges on whether the Quanta partnership can transform Rigetti from a boutique fabricator into a volume manufacturer before its current capital reserves are depleted. While the fortress balance sheet provides a temporary cushion, the lack of diversified, recurring commercial revenue remains the primary headwind. Investors must weigh the genuine technological progress and strategic partnerships against the persistent operating losses and concentrated customer base.